NCT03901651

Brief Summary

Colonoscopy is the standard of care for the detection of colorectal polyps and adenoma, and colorectal cancer detection. Despite a meticulous evaluation of the colonic mucosa during colonoscopy, a substantial number of colorectal polyps might be missed and colorectal cancer might not be prevented. Previous studies described a 12-28% of miss-rate for all polyps, a 31% for hyperplastic polyps and 6-27% for adenomas, with a higher miss rate noted for smaller polyps. The lesion missing rate depends on several factors, such as the location on difficult areas to be evaluated with conventional colonoscopes (the proximal side of the ileocecal valve, haustral folds, flexures or rectal valves), a flat shape, an inadequate bowel preparation and inadequate endoscopy technique, a time-limited colonoscope withdrawal. If the standard 140º angle of view colonoscope is used approximately 13% of the colonic surface is unevaluated. The incorporation of colonoscopes with a 170-degree wide angled could improve adenoma detection rate. The introduction of high definition (HD) colonoscopes and visual image enhancement technologies, such as narrow band imaging (NBI, Olympus America, Center Valley, PA), I-SCAN™ (Pentax Medical, Montvale, NJ) and Fuji Intelligent Chromo-Endoscopy (FICE™, Fujinon Endoscopy, Wayne, NJ) have improved the lesion characterization; however, several studies have failed to prove an increase in the adenoma detection rates. The Third Eye Retroscope (Avantis Medical Systems, Sunnyvale, CA) is a disposable retrograde viewing device advanced through the accessory channel of a standard colonoscope. It allows retrograde viewing behind colonic folds and flexures simultaneously with the forward view of the colon. Although it shows an increase in the adenoma detection rate by 11%-25%, it has many disadvantages. First, it requires a separate processor and the device is disposable, increasing the cost of the procedure. Second, it occupies the working channel of the colonoscope, limiting the ability to suction. Third, if a polyp is detected, the viewing device has to be removed in order to perform the polypectomy. Fourth, the optic is not high definition and finally, the endoscopist has to get used to visualizing and processing two simultaneous video streams from the colonoscopy and from the retroscope device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
203

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 25, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 3, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
Last Updated

June 2, 2021

Status Verified

June 1, 2021

Enrollment Period

1.9 years

First QC Date

March 25, 2019

Last Update Submit

June 1, 2021

Conditions

Keywords

colonic polyps

Outcome Measures

Primary Outcomes (2)

  • Polyp detection rate with standard colonoscope and the Retroview colonoscope

    Polyps found during standard colonoscopy/total of polyps found x 100; polyps found with the Retroview scope/total of polyps found x100. The total of polyps found will be defined by the combination of both methods

    23 months

  • Adenoma detection rate with standard colonoscope and retroview colonoscope.

    Adenomas found during standard colonoscopy/total of adenomas found x 100; adenomas found with the Retroview scope/total of adenomas found x100. The total of adenomas found will be defined by the combination of both methods

    23 months

Secondary Outcomes (3)

  • Lesion miss rate with the standard colonoscope and Retroview scope

    23 months

  • Number of lesions (adenomas and polyps) detected with the standard colonoscope and Retroview colonoscope.

    23 months

  • Size of lesions (adenomas and polyps) detected with the standard colonoscope and Retroview colonoscope.

    23 months

Study Arms (2)

Standard colonoscopy

ACTIVE COMPARATOR

Patients submitted for screening, surveillance or diagnostic colonoscopy. A standard colonoscopy with forwarding viewing withdrawal technique. An HD colonoscope with I-scan technology will be used by one expert endoscopist. Each polyp and adenoma will be recorded, including the size and location. Polyps will be removed before the second procedure.

Diagnostic Test: Colonoscopy with standard colonoscope and forward withdrawal technique

Retroview colonoscopy

EXPERIMENTAL

The same group of patients. A second colonoscopy using a combined forward and retroflexed evaluation of the colonic mucosa. using the Retroview™ scope. The operator will be blind to the first colonoscopy findings. The operator will record the polyps and adenoma encountered, describing the size and location.

Diagnostic Test: Colonoscopy with Retroview scope combing forward and retroflexed withdrawal technique

Interventions

Colonoscopy using a combined forward and retroflexed evaluation of the colonic mucosa. using the Retroview™ scope. The operator will be blind to the standard colonoscopy findings. The operator will record the polyps and adenoma encountered, describing the size and location.

Retroview colonoscopy

A standard colonoscopy with forwarding viewing withdrawal technique. An HD colonoscope with I-scan technology will be used by one expert endoscopist. Each polyp and adenoma will be recorded, including the size and location.

Standard colonoscopy

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients capable of providing written consent
  • Colonoscopy indicated for colorectal cancer screening or surveillance
  • Patients submitted for polypectomy
  • Colonoscopy indicated for diagnostic purposes: anemia, abdominal pain, constipation, alteration of bowel habits.

You may not qualify if:

  • Patients under 45 years and over 80 years of age.
  • Pregnancy and/or nursing.
  • Patients with past-medical history of cardiac, renal, hepatic or severe metabolic diseases
  • Unable to tolerate sedation
  • Severe uncontrolled coagulopathy
  • Past surgical history of colonic resection, ileostomy or colostomy.
  • Previous abdominal or pelvic radiation therapy.
  • Patients with inflammatory bowel disease, polyposis syndrome or acute diverticulitis.
  • Patients with high suspicion of colonic obstruction or history of prior obstruction.
  • Patients with gastrointestinal bleeding.
  • Inadequate bowel preparation. The bowel preparation will be evaluated using the Boston Bowel Preparation Scale. Patients with \< 2 points in at least one of the three segments of the colon will be excluded.
  • Patients who after the beginning of the colonoscopy have to be suspended due to the inability to reach into the cecum because of unfavorable anatomy or impassable tumors/stenosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ecuadorian Institute of Digestive Diseases

Guayaquil, Guayas, 090505, Ecuador

Location

MeSH Terms

Conditions

Colonic PolypsColonic Neoplasms

Interventions

Colonoscopy

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Carlos Robles-Medranda, MC

    Instituto Ecuatoriano de Enfermedades Digestivas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Patients submitted for screening, surveillance or diagnostic colonoscopy. First, a colonoscopy using a HD standard colonoscope using a forward viewing withdrawal technique. Then, a second colonoscopy using the Retroview colonoscope combining forward and retroflexed evaluation of the colon will be performed in the same patient.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2019

First Posted

April 3, 2019

Study Start

January 2, 2019

Primary Completion

December 1, 2020

Study Completion

January 1, 2021

Last Updated

June 2, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations